Dr. Matthew James Copeland, DO

Dr. Copeland practices at Medstar Georgetown Medical Center in Washington, District of Columbia.

Dr. Copeland's NPI, 1396130944, was assigned on March 31, 2015. Dr. Copeland graduated from West Virginia School of Osteopathic Medicine in 2015. Dr. Copeland holds District of Columbia license DO034743.

Dr. Copeland's primary practice is Medstar Georgetown Medical Center, at 3800 Reservoir NW Rd, Washington, DC 20007 in District Of Columbia County. The practice phone is (202) 444-1400.

Dr. Copeland's primary practice is Medstar Georgetown Medical Center in Washington, District of Columbia. Dr. Copeland is also affiliated with MedStar Georgetown University Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Copeland to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Copeland practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Copeland's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Copeland is licensed in District of Columbia.

CMS data shows 599 Medicare services from Dr. Copeland across 6 procedure codes in 2024, for 221 Medicare patients. Medicare paid $64,209 for them.

CMS counts 221 Medicare patients who saw Dr. Copeland in 2024. The largest group is 65 to 74, with 95 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 29% are also on Medicaid. Their average risk score is 3.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Copeland's median patient age at 57, with 43% women.

In 2024, Dr. Copeland wrote 241 Medicare Part D claims for 46 patients. 53% of them were for generic drugs. CMS names the drug for 166 of them, across 9 drugs with 11 or more claims each, at $353,414 in total drug cost. In 2023, CMS named 104 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Copeland for performance year 2024, reported as part of a group. Dr. Copeland accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Copeland as offering telehealth.

Dmand AI links 3 papers to Dr. Copeland, published from 2022 to 2024. The most frequent topics are Monkeypox virus and Mpox, Monkeypox. Dr. Copeland's most frequent co-authors are Rebecca Nirmal Kumar, MD, Kelli M. Money, MD and Daniel Michael Pastula, MD, MHS.

CMS Open Payments shows 16 general payments to Dr. Copeland from 2 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 55% of the total. Gilead Sciences, Inc. paid the most, $192.

Dr. Copeland graduated from West Virginia School of Osteopathic Medicine in 2015.